Meeting the Needs of Early-Phase Drug Sponsors with HPAPIs in the Pipeline
Summary: This webinar aims to address the specific needs of sponsors by providing valuable insights and practical strategies. Experts will explore…
Achieving Desired Particle Size and Yield Through Efficient Micronization
Summary: During this webinar learn with the right combination of technology and expertise, micronization can help to overcome many of the challenges faced by small molecule drugs and address the challenges and solutions to scale, yield and cost of goods.
Preclinical Toxicology vs Clinical: Key Considerations in Using Lipid-based Formulations
Summary: In this webinar, experts offer insights into the perceived barriers to developing LBFs and recent advances in translating them into useful clinical and commercial products of lipophilic drugs.
Targeted Protein Degraders: Through the Lens of the Innovation, Developability, and CMC Challenges
Summary: In this webinar, experts review the trends and challenges associated with the rational design of targeted protein degrader drugs.
Leveraging Oral Solid Dose Technologies for the Development and Manufacturing of Potent Treatments
Industry experts as they delve into the driving forces that have created the recent surge in treatments for oncology and rare disease.